Literature DB >> 1137244

Normal values and evaluation of forced end-expiratory flow.

J F Morris, A Koski, J D Breese.   

Abstract

A new spirometric measurement was performed with 803 healthy, nonsmoking men and women. Using the forced vital capacity curves, the forced end-expiratory flow (FEF75-85%) had a negative correlation with age and a positive correlation with height. Prediction formulas and nomograms were constructed. Comparison with the forced mid-expiratory flow (FEF25-75%) showed generally larger correlation coefficients for physical characteristics and coefficients of variation for the FEF75-85%. Expressing both the FEF75-85% and FEF25-75% as ratios of forced vital capacity did not improve the coefficients. The mean flow rates of 75 male smokers were compared with 213 non-smokers 30 to 49 years of age. The FEF75-85% significantly distinguished between a group of smokers and a group of nonsmokers, but the FEF25-75% showed no significant difference. In 9 patients with presumed peripheral airways disease, FEF25-75% ranged from 70 to 110 per cent of predicted normal but FEF75-85% was 30 to 72 per cent of predicted. An extensively studied control group of 22 healthy, asymptomatic, nonsmoking subjects had FEF75-85% values of 80 to 163 per cent of predicted. Both small groups of 9 patients and 22 control subjects had FEF75-85% values within 1.65 standard error of estimate. In subgroups of 319 persons, use of 75 per cent of predicted mean for FEF75-85% was of greater value in attempting to screen normal from abnormal population than using 1.65 standard error of estimate. The FEF75-85% is suggested as a useful simple ventilatory test to detect early obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1975        PMID: 1137244     DOI: 10.1164/arrd.1975.111.6.755

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial.

Authors:  N L Risser; D W Belcher
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

2.  Spirometry in the evaluation of pulmonary function.

Authors:  J F Morris
Journal:  West J Med       Date:  1976-08

3.  Lung function in essential mixed cryoglobulinemia: a short-term follow-up.

Authors:  G Viegi; E Fornai; C Ferri; O Di Munno; E Begliomini; C Vitali; F Melocchi; S Bombardieri; P Paoletti
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

4.  Respiratory hazards in hard metal workers: a cross sectional study.

Authors:  C Meyer-Bisch; Q T Pham; J M Mur; N Massin; J J Moulin; D Teculescu; B Carton; F Pierre; F Baruthio
Journal:  Br J Ind Med       Date:  1989-05

5.  Kaolin dust concentrations and pneumoconiosis at a kaolin mine.

Authors:  E B Altekruse; B A Chaudhary; M G Pearson; W K Morgan
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

6.  Pulmonary involvement in primary biliary cirrhosis.

Authors:  R Rodriguez-Roisin; A Pares; M Bruguera; J Coll; C Picado; A Agusti-Vidal; F Burgos; J Rodes
Journal:  Thorax       Date:  1981-03       Impact factor: 9.139

7.  The site of airway obstruction among patients of emphysema: role of impulse oscillometry.

Authors:  Hs Hira; Jitender Munjal; Sanjay Zachariah; Mr Chauhan; Anshu Singh
Journal:  Lung India       Date:  2008-01

8.  Time course of lung function changes in atypical pneumonia.

Authors:  L N Benusiglio; H Stalder; A F Junod
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

9.  Lung function abnormalities in different connective tissue diseases.

Authors:  C Vitali; G Viegi; S Tassoni; A Tavoni; P Paoletti; E Bibolotti; C Ferri; S Bombardieri
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

10.  Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome.

Authors:  C Vitali; A Tavoni; G Viegi; E Begliomini; A Agnesi; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.